UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:June 06, 2023
Accession Number:0001104659-23-066683
Submission Type:POS AM
CIK:0001541157
Company Name:Akari Therapeutics Plc
File Number:333-233048
Akari Therapeutics (NASDAQ:AKTX)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Akari Therapeutics.
Akari Therapeutics (NASDAQ:AKTX)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Akari Therapeutics.